The University of Chicago Header Logo

Connection

James Millis to Male

This is a "connection" page, showing publications James Millis has written about Male.
Connection Strength

0.436
  1. Crohn disease and intestinal transplantation: benefit balance. JAMA Surg. 2014 Oct; 149(10):1067.
    View in: PubMed
    Score: 0.026
  2. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66.
    View in: PubMed
    Score: 0.025
  3. Are surgeons rising to the challenge of managing morbidly obese patients undergoing hepatic resection? Arch Surg. 2012 Apr; 147(4):337.
    View in: PubMed
    Score: 0.022
  4. Biocompatibility investigation of polyethylene glycol and alginate-poly-L-lysine for islet encapsulation. ASAIO J. 2010 May-Jun; 56(3):241-5.
    View in: PubMed
    Score: 0.019
  5. Giant necrotizing abscess of a liver transplant after gunshot injury. Transplantation. 2007 Nov 27; 84(10):1373-4.
    View in: PubMed
    Score: 0.016
  6. Retained colorectal foreign bodies. Dis Colon Rectum. 2006 Aug; 49(8):1240-1; author reply; 1241.
    View in: PubMed
    Score: 0.015
  7. Omega jejunoduodenal anastomosis for pancreas transplant. J Am Coll Surg. 2006 Jun; 202(6):1021-4.
    View in: PubMed
    Score: 0.015
  8. Combined kidney-pancreas transplant: early abdominal catastrophe in the donor may not be a contraindication. Transplantation. 2006 Apr 27; 81(8):1223.
    View in: PubMed
    Score: 0.015
  9. Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact. Transplantation. 2002 Dec 27; 74(12):1735-46.
    View in: PubMed
    Score: 0.012
  10. Long-term venous complications after full-size and segmental pediatric liver transplantation. Ann Surg. 2002 Nov; 236(5):658-66.
    View in: PubMed
    Score: 0.012
  11. The impact of donor factors on the outcomes following liver transplantation. Transplant Proc. 2002 Aug; 34(5):1495-6.
    View in: PubMed
    Score: 0.011
  12. Devastating and fatal complications associated with combined vascular and bile duct injuries during cholecystectomy. Arch Surg. 2002 Jun; 137(6):703-8; discussion 708-10.
    View in: PubMed
    Score: 0.011
  13. Is any method of vascular control superior in hepatic resection of metastatic cancers? Longmire clamping, pringle maneuver, and total vascular isolation. Arch Surg. 2001 May; 136(5):569-75.
    View in: PubMed
    Score: 0.010
  14. Suction thrombectomy and stent grafting of inferior vena cava thrombus following primary repair of traumatic inferior vena cava injury. J Trauma Acute Care Surg. 2021 05 01; 90(5):e123-e125.
    View in: PubMed
    Score: 0.010
  15. Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation. Cell Transplant. 2021 Jan-Dec; 30:9636897211001774.
    View in: PubMed
    Score: 0.010
  16. Pancreatic beta cell/islet mass and body mass index. Islets. 2019; 11(1):1-9.
    View in: PubMed
    Score: 0.009
  17. Assessment of simple indices based on a single fasting blood sample as a tool to estimate beta-cell function after total pancreatectomy with islet autotransplantation - a prospective study. Transpl Int. 2019 03; 32(3):280-290.
    View in: PubMed
    Score: 0.009
  18. Complications in 100 living-liver donors. Ann Surg. 1998 Aug; 228(2):214-9.
    View in: PubMed
    Score: 0.009
  19. Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after islet transplantation. Am J Transplant. 2018 04; 18(4):990-997.
    View in: PubMed
    Score: 0.008
  20. Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis. 1998; 21 Suppl 1:112-8.
    View in: PubMed
    Score: 0.008
  21. A Multicenter Study: North American Islet Donor Score in Donor Pancreas Selection for Human Islet Isolation for Transplantation. Cell Transplant. 2016; 25(8):1515-1523.
    View in: PubMed
    Score: 0.007
  22. Preservation of beta cell function after pancreatic islet autotransplantation: University of Chicago experience. Am Surg. 2015 Apr; 81(4):421-7.
    View in: PubMed
    Score: 0.007
  23. Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes. Endocrine. 2015 Aug; 49(3):693-702.
    View in: PubMed
    Score: 0.007
  24. Chronic pancreatitis and primary sclerosing cholangitis--first report of intrahepatic autologous islet transplantation. J Gastrointest Surg. 2014 Apr; 18(4):845-50.
    View in: PubMed
    Score: 0.006
  25. Regional differences in islet distribution in the human pancreas--preferential beta-cell loss in the head region in patients with type 2 diabetes. PLoS One. 2013; 8(6):e67454.
    View in: PubMed
    Score: 0.006
  26. Expanding the envelope: the posterior rectus sheath-liver vascular composite allotransplant. Plast Reconstr Surg. 2013 Feb; 131(2):209e-218e.
    View in: PubMed
    Score: 0.006
  27. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26.
    View in: PubMed
    Score: 0.006
  28. Use of immune function test in monitoring immunosuppression in liver transplant recipients. Clin Transplant. 2012 Nov-Dec; 26(6):826-32.
    View in: PubMed
    Score: 0.006
  29. Liver and vascularized posterior rectus sheath fascia composite tissue allotransplantation. Am J Transplant. 2010 Dec; 10(12):2712-6.
    View in: PubMed
    Score: 0.005
  30. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010 Nov 18; 363(21):2004-14.
    View in: PubMed
    Score: 0.005
  31. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut. 2010 Dec; 59(12):1687-93.
    View in: PubMed
    Score: 0.005
  32. Entecavir therapy in a hepatitis B-related decompensated cirrhotic patient. South Med J. 2008 Nov; 101(11):1173-6.
    View in: PubMed
    Score: 0.004
  33. Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization. Dig Liver Dis. 2009 Feb; 41(2):175-6.
    View in: PubMed
    Score: 0.004
  34. Orthotopic liver transplantation for biliary atresia. Evolution of management. Arch Surg. 1988 Oct; 123(10):1237-9.
    View in: PubMed
    Score: 0.004
  35. Current state of combined heart-liver transplantation in the United States. J Heart Lung Transplant. 2008 Jul; 27(7):753-9.
    View in: PubMed
    Score: 0.004
  36. Impact of graft type on outcome in pediatric liver transplantation: a report From Studies of Pediatric Liver Transplantation (SPLIT). Ann Surg. 2007 Aug; 246(2):301-10.
    View in: PubMed
    Score: 0.004
  37. Hepato-spleno-mesenteric trunk. J Am Coll Surg. 2007 Mar; 204(3):511.
    View in: PubMed
    Score: 0.004
  38. Transjugular intrahepatic portosystemic shunt placement in liver transplant recipients: experiences with pediatric and adult patients. AJR Am J Roentgenol. 2005 Mar; 184(3):920-5.
    View in: PubMed
    Score: 0.003
  39. Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results. Transplantation. 2004 Apr 27; 77(8):1269-75.
    View in: PubMed
    Score: 0.003
  40. Epidemiology and clinical consequences of vancomycin-resistant enterococci in liver transplant patients. Transplantation. 2001 Sep 27; 72(6):1032-7.
    View in: PubMed
    Score: 0.003
  41. Risk factors for chronic rejection after pediatric liver transplantation. Transplantation. 2001 Sep 27; 72(6):1098-102.
    View in: PubMed
    Score: 0.003
  42. Open cardiotomy for removal of migrating transjugular intrahepatic portosystemic shunt stent combined with liver transplantation. Transplantation. 2001 Apr 15; 71(7):1000-3.
    View in: PubMed
    Score: 0.003
  43. De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation. 2001 Mar 15; 71(5):664-8.
    View in: PubMed
    Score: 0.003
  44. Surgical management of benign tumors of the liver. Int J Gastrointest Cancer. 2001; 30(3):141-6.
    View in: PubMed
    Score: 0.003
  45. Hepatic resection: effective treatment for primary and secondary tumors. Surgery. 2000 Oct; 128(4):686-93.
    View in: PubMed
    Score: 0.002
  46. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg. 2000 May; 135(5):530-4; discussion 534-5.
    View in: PubMed
    Score: 0.002
  47. Successful combined liver-heart transplantation in adults: report of three patients and review of the literature. Transplantation. 1999 Nov 15; 68(9):1423-7.
    View in: PubMed
    Score: 0.002
  48. Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients. Transplantation. 1999 Jun 27; 67(12):1562-8.
    View in: PubMed
    Score: 0.002
  49. Liver transplantation in the first three months of life. Transplantation. 1998 Sep 15; 66(5):606-9.
    View in: PubMed
    Score: 0.002
  50. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. Transplant Proc. 1998 Jun; 30(4):1234-5.
    View in: PubMed
    Score: 0.002
  51. Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen. Transplant Proc. 1998 Jun; 30(4):1249-50.
    View in: PubMed
    Score: 0.002
  52. Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. Transplant Proc. 1998 Jun; 30(4):1378-9.
    View in: PubMed
    Score: 0.002
  53. Duodenum and duodenal-jejunal junction in children: position and appearance after liver transplantation. Radiology. 1998 Apr; 207(1):233-6.
    View in: PubMed
    Score: 0.002
  54. Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases. Transplant Proc. 1998 Mar; 30(2):270-1.
    View in: PubMed
    Score: 0.002
  55. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Mar; 30(2):507-8.
    View in: PubMed
    Score: 0.002
  56. Transjugular intrahepatic portosystemic shunt creation in children: initial clinical experience. Radiology. 1998 Jan; 206(1):109-14.
    View in: PubMed
    Score: 0.002
  57. Reversal of accelerated renal allograft rejection with FK 506. Clin Transplant. 1997 Aug; 11(4):251-4.
    View in: PubMed
    Score: 0.002
  58. Coccidioidomycosis in liver transplant patients. Clin Infect Dis. 1997 Feb; 24(2):216-21.
    View in: PubMed
    Score: 0.002
  59. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Transplantation. 1996 Oct 15; 62(7):906-10.
    View in: PubMed
    Score: 0.002
  60. Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation. 1996 Aug 27; 62(4):451-6.
    View in: PubMed
    Score: 0.002
  61. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
    View in: PubMed
    Score: 0.002
  62. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection. Clin Transplant. 1996 Aug; 10(4):389-95.
    View in: PubMed
    Score: 0.002
  63. Living-donor liver transplantation at UCLA. Am J Surg. 1995 May; 169(5):529-32.
    View in: PubMed
    Score: 0.002
  64. Radical resection combined with liver transplantation for foregut tumors. Am Surg. 1993 Dec; 59(12):806-12.
    View in: PubMed
    Score: 0.002
  65. Celiac compression syndrome and liver transplantation. Ann Surg. 1993 Jul; 218(1):10-2.
    View in: PubMed
    Score: 0.002
  66. Effects of tumor necrosis factor (TNF) and immunotherapy directed against TNF on rat cardiac transplants. Transplant Proc. 1991 Feb; 23(1 Pt 1):233-4.
    View in: PubMed
    Score: 0.001
  67. Liver transplantation in children. Ann Surg. 1991 Jan; 213(1):48-57.
    View in: PubMed
    Score: 0.001
  68. The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection. Transplantation. 1991 Jan; 51(1):57-62.
    View in: PubMed
    Score: 0.001
  69. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg. 1990 Oct; 125(10):1261-6; discussion 1266-8.
    View in: PubMed
    Score: 0.001
  70. Influence of number and timing of serum transfusions on liver allograft survival in rats. Transplant Proc. 1990 Aug; 22(4):2020-2.
    View in: PubMed
    Score: 0.001
  71. Anti-tumor necrosis factor antibody enhances allograft survival in rats. J Surg Res. 1990 Apr; 48(4):345-8.
    View in: PubMed
    Score: 0.001
  72. Comparison of UW solution and Euro-Collins solutions for cold preservation of human liver grafts. Transplantation. 1990 Feb; 49(2):284-90.
    View in: PubMed
    Score: 0.001
  73. Hepatic artery reconstruction during liver transplantation. Transplantation. 1989 Feb; 47(2):403-6.
    View in: PubMed
    Score: 0.001
  74. The quality of survival after liver transplantation. Transplant Proc. 1988 Feb; 20(1 Suppl 1):594-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.